News
The sale was for $256 million and is expected to be complete by the third quarter of this year, according to a Regeneron news ...
Genetics company 23andMe is expected to be purchased by Regeneron Pharmaceuticals, according to announcements shared by both ...
On Monday, Regeneron Pharmaceuticals announced that it would acquire most of 23andMe's assets for $256 million. According to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results